Trupanion (NASDAQ:TRUP) Price Target Lowered to $28.00 at Piper Sandler

Trupanion (NASDAQ:TRUP - Get Free Report) had its target price dropped by analysts at Piper Sandler from $32.00 to $28.00 in a research note issued to investors on Friday, Benzinga reports. The firm presently has a "neutral" rating on the financial services provider's stock. Piper Sandler's price target suggests a potential upside of 7.28% from the stock's current price.

A number of other brokerages have also recently weighed in on TRUP. Stifel Nicolaus lifted their price target on shares of Trupanion from $25.00 to $28.00 and gave the stock a "hold" rating in a research report on Friday, February 16th. Evercore ISI reduced their price target on shares of Trupanion from $35.00 to $31.00 and set an "outperform" rating on the stock in a research report on Tuesday, February 20th. Four analysts have rated the stock with a hold rating and one has issued a buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $33.20.

Trupanion Trading Up 2.3 %

TRUP traded up $0.59 during trading on Friday, reaching $26.10. 543,164 shares of the company's stock were exchanged, compared to its average volume of 695,258. The company's fifty day moving average price is $27.49 and its 200-day moving average price is $27.25. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.63 and a current ratio of 1.63. Trupanion has a fifty-two week low of $18.45 and a fifty-two week high of $45.50. The firm has a market capitalization of $1.09 billion, a PE ratio of -24.17 and a beta of 1.71.

Trupanion (NASDAQ:TRUP - Get Free Report) last released its earnings results on Thursday, February 15th. The financial services provider reported ($0.05) EPS for the quarter, topping analysts' consensus estimates of ($0.18) by $0.13. Trupanion had a negative net margin of 4.03% and a negative return on equity of 15.19%. The firm had revenue of $295.50 million during the quarter, compared to analyst estimates of $289.84 million. During the same quarter in the previous year, the business earned ($0.23) EPS. The business's quarterly revenue was up 20.1% compared to the same quarter last year. As a group, equities analysts forecast that Trupanion will post -0.43 EPS for the current year.

Institutional Investors Weigh In On Trupanion

Several institutional investors have recently added to or reduced their stakes in TRUP. Sivia Capital Partners LLC bought a new stake in Trupanion in the 4th quarter valued at $31,398,000. 8 Knots Management LLC bought a new stake in Trupanion in the 4th quarter valued at $21,165,000. Wellington Management Group LLP lifted its position in Trupanion by 34.6% in the 4th quarter. Wellington Management Group LLP now owns 2,453,685 shares of the financial services provider's stock valued at $74,862,000 after acquiring an additional 630,155 shares in the last quarter. JPMorgan Chase & Co. lifted its position in Trupanion by 123.7% in the 2nd quarter. JPMorgan Chase & Co. now owns 110,222 shares of the financial services provider's stock valued at $6,643,000 after acquiring an additional 576,020 shares in the last quarter. Finally, Bank of America Corp DE lifted its position in Trupanion by 315.5% in the 1st quarter. Bank of America Corp DE now owns 654,008 shares of the financial services provider's stock valued at $28,050,000 after acquiring an additional 496,619 shares in the last quarter.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.